Showing results 1 to 20 of 24
next >
| Issue Date | Title | Author(s) |
| Jan-2022 | Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection | Wang, Yifan; Duan, Fugang; Zhu, Zhu; Yu, Meng; Jia, Xiaodong; Dai, Hui; Wang, Pingzhang; Qiu, Xiaoyan; Lu, Yinying; Huang, Jing |
| Dec-2022 | Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors | Lei, Jin; Yan, Tao; Zhang, Linzhi; Chen, Bowen; Cheng, Jiamin; Gao, Xiaoqiang; Liu, Zherui; Li, Yinyin; Zuo, Shi; Lu, Yinying |
| 2024 | Degradation of FAK-targeting by proteolytic targeting chimera technology to inhibit the metastasis of hepatocellular carcinoma | Zhang, Xinfeng; Li, Shuang; Song, Meiru; Chen, Yue; Chang, Liangzheng; Liu, Zherui; Dai, Hongyuan; Wang, Yutao; Yang, Gangqi; Jiang, Yun; Lu, Yinying |
| 1-Jun-2022 | Efficacy and safety in advanced hepatocellular carcinoma using atezolizumab plus bevacizumab combined with interventional therapy: A retrospective analysis of real-world evidence. | Cheng, Jiamin; Chen, Bowen; Jing, Yi; Lu, Yinying |
| 1-Jun-2023 | Efficacy and safety in unresectable hepatocellular carcinoma using atezolizumab plus bevacizumab in later-line: A retrospective analysis of real-world evidence. | Cheng, Jiamin; Chen, Bowen; Zhang, Xinfeng; Su, Guodong; Peng, Caiyun; Zhou, Lin; Lei, Jin; Li, Yinyin; Lu, Yinying |
| 1-Jun-2023 | Efficacy and safety in unresectable hepatocellular carcinoma with VP4 tumor embolus using sinilimab plus bevacizumab: A retrospective analysis of real-world evidence | Cheng, Jiamin; Chen, Bowen; Zhang, Xinfeng; Su, Guodong; Peng, Caiyun; Lei, Jin; Yu, Lingxiang; Li, Yinyin; Lu, Yinying |
| Oct-2021 | EFFICACY AND SAFETY OF LENVATINIB COMBINED WITH DIFFERENT ANTI-PD-1 ANTIBODY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A REAL WORLD EVIDENCE BASED RETROSPECTIVE STUDY | Chen, Bowen; Zhang, Linzhi; Cheng, Jiamin, Sr.; Yan, Tao; Lu, Yinying |
| 2022 | Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study | Chen, Bowen; Lei, Jin; Zhao, Haitao; Dong, Jinghui; Zeng, Zhen; Li, Yinyin; Yu, Lingxiang; Zhou, Lin; Jia, Aiying; Lu, Yinying; Cheng, Jiamin |
| 2023 | Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma | Lei, Jin; Yang, Sibo; Chen, Bowen; Zhang, Linzhi; Yan, Tao; Yang, Gangqi; Chen, Yue; Li, Yinyin; Lu, Yinying; Zuo, Shi |
| 9-Dec-2022 | Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinoma | Xie, Fucun; Chen, Bowen; Yang, Xu; Wang, Huaiyuan; Zhang, Ge; Wang, Yanyu; Wang, Yunchao; Zhang, Nan; Xue, Jingnan; Long, Junyu; Li, Yiran; Sun, Huishan; Xun, Ziyu; Liu, Kai; Chen, Xiangqi; Song, Yang; Yang, Xiaobo; Lu, Zhenhui; Mao, Yilei; Sang, Xinting; Lu, Yinying; Zhao, Haitao |
| 2019 | Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes | Xue, Ruidong; Chen, Lu; Zhang, Chong; Fujita, Masashi; Li, Ruoyan; Yan, Shu-Mei; Ong, Choon Kiat; Liao, Xiwen; Gao, Qiang; Sasagawa, Shota; Li, Yanmeng; Wang, Jincheng; Guo, Hua; Huang, Qi-Tao; Zhong, Qian; Tan, Jing; Qi, Lisha; Gong, Wenchen; Hong, Zhixian; Li, Meng; Zhao, Jingmin; Peng, Tao; Lu, Yinying; Lim, Kiat Hon Tony; Boot, Arnoud; Ono, Atushi; Chayama, Kazuaki; Zhang, Zemin; Rozen, Steve George; Teh, Bin Tean; Wang, Xin Wei; Nakagawa, Hidewaki; Zeng, Mu-Sheng; Bai, Fan; Zhang, Ning |
| 8-Mar-2022 | Intestinal Candida albicans Promotes Hepatocarcinogenesis by Up-Regulating NLRP6 | Liu, Zherui; Li, Yinyin; Li, Chen; Lei, Guanglin; Zhou, Lin; Chen, Xiangling; Jia, Xiaodong; Lu, Yinying |
| 1-Jun-2022 | Lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma: A large real-world study from two centers. | Yang, Xu; Chen, Bowen; Wang, Yanyu; Wang, Yunchao; Long, Junyu; Zhang, Nan; Xue, Jinnan; Xun, Ziyu; Zhang, Linzhi; Cheng, Jiamin; Lei, Jin; Pan, Jie; Hu, Ke; Guan, Mei; Huo, Li; Mao, Yilei; Sang, Xinting; Lu, Yinying; Zhao, Hai-Tao |
| 2018 | A New Nomogram Predicting Overall Survival of Patients with Intrahepatic Cholangiocarcinoma | Zhang, Ning; Lu, Shanshan; Wu, Yao; Hong, Na; Lu, Yinying |
| 2018 | A New Nomogram Predicting Overall Survival of Patients with Intrahepatic Cholangiocarcinoma | Zhang, Ning; Lu, Shanshan; Wu, Yao; Hong, Na; Lu, Yinying |
| 5-Jul-2022 | A new strategy: identification of specific antibodies for neutralizing epitope on SARS-CoV-2 S protein by LC-MS/MS combined with immune repertoire | Yu, Meng; Zhu, Zhu; Wang, Yanqun; Wang, Pingzhang; Jia, Xiaodong; Wang, Jie; Liu, Lei; Liu, Wanbing; Zheng, Yaqiong; Kou, Guomei; Xu, Weiyan; Huang, Jing; Lu, Fengmin; Zou, Xiajuan; Zheng, Shangen; Lu, Yinying; Zhao, Jincun; Dai, Hui; Qiu, Xiaoyan |
| Mar-2024 | NLRP6 deficiency suppresses colorectal cancer liver metastasis growth by modulating M-MDSC-induced immunosuppressive microenvironment | Chang, Liangzheng; Xu, Lei; Tian, Yuying; Liu, Zherui; Song, Meiru; Li, Shuang; Zhang, Xinfeng; Chen, Yue; Hao, Qiuyao; Lu, Yinying; Zhen, Yunhuan |
| 28-Feb-2022 | A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex | Duan, Fugang; Wang, Yifan; Chen, Taoyu; Zhu, Zhu; Yu, Meng; Dai, Hui; Zheng, Shangen; Lu, Yinying; Li, Tingting; Qiu, Xiaoyan |
| Apr-2024 | Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer | Yang, Hui; Cheng, Jinghui; Zhuang, Hao; Xu, Hongchuang; Wang, Yinuo; Zhang, Tingting; Yang, Yinmo; Qian, Honggang; Lu, Yinying; Han, Feng; Cao, Lihua; Yang, Nanmu; Liu, Rong; Yang, Xing; Zhang, Jiangong; Wu, Jianmin; Zhang, Ning |
| Feb-2023 | Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients | Yang, Xu; Chen, Bowen; Wang, Yanyu; Wang, Yunchao; Long, Junyu; Zhang, Nan; Xue, Jingnan; Xun, Ziyu; Zhang, Linzhi; Cheng, Jiamin; Lei, Jin; Sun, Huishan; Li, Yiran; Lin, Jianzhen; Xie, Fucun; Wang, Dongxu; Pan, Jie; Hu, Ke; Guan, Mei; Huo, Li; Shi, Jie; Yu, Lingxiang; Zhou, Lin; Zhou, Jinxue; Lu, Zhenhui; Yang, Xiaobo; Mao, Yilei; Sang, Xinting; Lu, Yinying; Zhao, Haitao |
